SCHEMBL9188784

SCHEMBL9188784

COc1ccc(/N=C/c2cc(OC)c(OC)c(OC)c2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.65
TUBB1 Q9H4B7 5/20 0.60
TUBB4A P04350 4/20 0.60
TUBB P07437 4/20 0.60
TUBA3C P0DPH7 4/20 0.60
TUBA1B P68363 4/20 0.60
TUBA4A P68366 4/20 0.60
TUBB4B P68371 4/20 0.60
TUBB3 Q13509 4/20 0.60
TUBB2A Q13885 4/20 0.60
TUBB8 Q3ZCM7 4/20 0.60
TUBA3E Q6PEY2 4/20 0.60
TUBA1A Q71U36 4/20 0.60
TUBA1C Q9BQE3 4/20 0.60
TUBB6 Q9BUF5 4/20 0.60
TUBB2B Q9BVA1 4/20 0.60
S100B P04271 1/20 0.57
CYP1B1 Q16678 3/20 0.50
CYP1A1 P04798 2/20 0.50
CYP1A2 P05177 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9188791 1.00 PTGS2 (0.65) PTGS2TUBB1TUBB4ATUBBTUBA3C
SCHEMBL8325327 0.87 S100B (0.66) PTGS2S100BCYP1B1PTGS1CA12
SCHEMBL9185802 0.87 PTGS2 (0.65) PTGS2TUBB1TUBB4ATUBBTUBA3C
SCHEMBL1995352 0.87 TUBB1 (0.60) PTGS2TUBB1TUBB4ATUBBTUBA3C
SCHEMBL9185811 0.87 PTGS2 (0.65) PTGS2TUBB1TUBB4ATUBBTUBA3C
SCHEMBL8325328 0.87 S100B (0.66) PTGS2S100BCYP1B1PTGS1CA12
SCHEMBL1995354 0.87 TUBB1 (0.60) PTGS2TUBB1TUBB4ATUBBTUBA3C
SCHEMBL9190495 0.86 TUBB4A (0.65) PTGS2TUBB1TUBB4ATUBBTUBA3C
SCHEMBL9190488 0.86 TUBB4A (0.65) PTGS2TUBB1TUBB4ATUBBTUBA3C
SCHEMBL12416851 0.85 PTGS2 (0.67) PTGS2TUBB1TUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5430062-A Combretastatin analogues; inhibition of tubulin polymerization and colchicine binding; antitumor,-mitotic and -neoplastic agents RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1995-07-04 US disclosed
WO-1993023357-A1 STILBENE DERIVATIVES AS ANTICANCER AGENTS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1993-11-25 WO disclosed